Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 2

2(40.0%)

Phase 3

1(20.0%)

5Total

N/A(2)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04387305Phase 3Not Yet Recruiting

Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study

Role: collaborator

NCT05910567Not ApplicableRecruiting

A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma

Role: collaborator

NCT06370520Recruiting

Screening Emotions in Adolescents at the Hospital for mTBI

Role: collaborator

NCT05373771Not ApplicableRecruiting

Sickle Cell Improvement: Enhancing Care in the Emergency Department

Role: collaborator

NCT02840097Phase 2Completed

Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study

Role: collaborator

NCT01197417Phase 2Completed

Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis

Role: collaborator

All 6 trials loaded